2022
DOI: 10.4103/ijo.ijo_1313_22
|View full text |Cite
|
Sign up to set email alerts
|

A review of techniques and outcomes of endothelial keratoplasty in congenital hereditary endothelial dystrophy

Abstract: Congenital hereditary endothelial dystrophy affects the Descemet membrane and endothelium, resulting in corneal decompensation. Penetrating keratoplasty (PKP) has been the gold-standard surgical management until recently; however, at present, endothelial keratoplasty (DSEK/DSAEK/n-DSEK: Descemet-stripping or non-Descemet stripping endothelial keratoplasty and DMEK/n-DMEK: Descemet membrane endothelial keratoplasty) is being preferred due to lesser intraoperative and postoperative complications, early visual re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 61 publications
(281 reference statements)
0
1
0
Order By: Relevance
“…EK with or without endothelial-Descemet stripping is proposed today as the procedure of choice for the surgical treatment of CHED by many authors [ 14 17 ]. More recently Descemet membrane endothelial keratoplasty (DMEK) has been also proposed as surgical treatment option for CHED with promising results, but the steeper learning curve and the intra-operative and postoperative technical challenges of DMEK are still limiting its wide adoption in children [ 15 , 18 , 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…EK with or without endothelial-Descemet stripping is proposed today as the procedure of choice for the surgical treatment of CHED by many authors [ 14 17 ]. More recently Descemet membrane endothelial keratoplasty (DMEK) has been also proposed as surgical treatment option for CHED with promising results, but the steeper learning curve and the intra-operative and postoperative technical challenges of DMEK are still limiting its wide adoption in children [ 15 , 18 , 19 ].…”
Section: Discussionmentioning
confidence: 99%